HUMAN PHOTOSYNTHESIS
LIVE

Serial Number

77748311

Owner

Formulas Magistrales SA de CV

Attorney

Holly M. Ford Lewis

First Use Date

Jun 11, 2005

Filing Date

May 30, 2009

Add to watchlist:

No watchlists yet
View on USPTO

HUMAN PHOTOSYNTHESIS Trademark

Serial Number: 77748311 • Registration: 4478337

HUMAN PHOTOSYNTHESIS is a trademark filed by Formulas Magistrales SA de CV on May 30, 2009. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Formulas Magistrales SA de CV (2 trademarks)

49 Marble Avenue
Pleasantville, NY 10570

Entity Type: 03

Trademark Details

Filing Date

May 30, 2009

Registration Date

February 4, 2014

First Use Anywhere

June 11, 2005

First Use in Commerce

January 25, 2013

Published for Opposition

April 27, 2010

Goods & Services

Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Homeopathic pharmaceuticals for smoking cessation; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Inhalers filled with nicotine for smoking cessation; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti- infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the prevention of arthritis, Alzheimer's disease, Parkinson's disease; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical products and preparations for chloasma; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, psychotropics; Plant extracts for medical, veterinary and pharmaceutical purposes; Therapeutic pharmaceutical for smoking cessation

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 8, 2026 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jun 8, 2026 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 8, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 8, 2026 REAP
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Dec 29, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 29, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 29, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 29, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 29, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 29, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 29, 2025 COAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Nov 5, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 5, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 5, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 5, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 5, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 5, 2025 COAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Apr 2, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 2, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 2, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 2, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 2, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 2, 2025 COAR
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Oct 21, 2023 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Oct 21, 2023 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Oct 21, 2023 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 21, 2023 APRE
TEAS SECTION 8 & 9 RECEIVED
Apr 25, 2023 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Feb 4, 2023 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Feb 21, 2020 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Feb 21, 2020 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 21, 2020 APRE
TEAS SECTION 8 & 15 RECEIVED
Dec 20, 2019 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 4, 2019 REM1
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 10, 2016 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 10, 2016 REAP
REGISTERED-PRINCIPAL REGISTER
Feb 4, 2014 R.PR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 28, 2014 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 28, 2014 REAP
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 1, 2014 SUNA
LAW OFFICE REGISTRATION REVIEW COMPLETED
Dec 31, 2013 REGV
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 20, 2013 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 19, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 19, 2013 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 19, 2013 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 9, 2013 GNFN
FINAL REFUSAL E-MAILED
Jul 9, 2013 GNFR
SU - FINAL REFUSAL - WRITTEN
Jul 9, 2013 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 9, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 9, 2013 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 2, 2013 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 2, 2013 GNRN
NON-FINAL ACTION E-MAILED
Jul 2, 2013 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jul 2, 2013 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Jun 26, 2013 SUPC
TEAS STATEMENT OF USE RECEIVED
Jun 24, 2013 EISU
USE AMENDMENT FILED
Jun 22, 2013 IUAF
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 10, 2013 EXRA
SOU EXTENSION 5 GRANTED
Jan 9, 2013 EX5G
PAPER RECEIVED
Dec 31, 2012 MAIL
SOU EXTENSION 5 FILED
Dec 22, 2012 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 21, 2012 EXRA
SOU EXTENSION 4 GRANTED
Jun 20, 2012 EX4G
SOU EXTENSION 4 FILED
Jun 19, 2012 EXT4
SOU TEAS EXTENSION RECEIVED
Jun 19, 2012 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 24, 2012 TCCA
UNDELIVERABLE MAIL - NO ACTION TAKEN
Feb 1, 2012 UNDN
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Jan 4, 2012 EXRA
SOU EXTENSION 3 GRANTED
Jan 3, 2012 EX3G
SOU EXTENSION 3 FILED
Dec 22, 2011 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 22, 2011 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Jun 25, 2011 EXRA
SOU EXTENSION 2 GRANTED
Jun 24, 2011 EX2G
SOU EXTENSION 2 FILED
Jun 22, 2011 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 22, 2011 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Jan 22, 2011 EXRA
SOU EXTENSION 1 GRANTED
Jan 21, 2011 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 21, 2011 AITU
SOU EXTENSION 1 FILED
Dec 22, 2010 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 22, 2010 EEXT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Jun 22, 2010 NOAM
PUBLISHED FOR OPPOSITION
Apr 27, 2010 PUBO
NOTICE OF PUBLICATION
Apr 7, 2010 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 22, 2010 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 17, 2010 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 16, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 16, 2010 CRFA
ASSIGNED TO LIE
Mar 16, 2010 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 3, 2010 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 3, 2009 GNRN
NON-FINAL ACTION E-MAILED
Sep 3, 2009 GNRT
NON-FINAL ACTION WRITTEN
Sep 3, 2009 CNRT
ASSIGNED TO EXAMINER
Aug 31, 2009 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 3, 2009 NWOS
NEW APPLICATION ENTERED
Jun 3, 2009 NWAP